The biotech market in the United States is experiencing a rapid surge in need for Tirzepatide APIs. This effective medication, used to treat type 2 diabetes, has captured remarkable attention from both patients and doctors. As a result, numerous firms have emerged as producers of Tirzepatide APIs in